Table 1 Demographic details of the study population

Study population

N = 629

Patients excluded (due to missing blood tests, dose changes)

N = 363

Patients included

N = 266

Mean age

64.3 (±9.5)

Racial setup

 Malay

N = 126

 Chinese

N = 71

 Indian

N = 69

Gender

 Male

N = 136

 Female

N = 130

Patients on lipid lowering drugs other than atorvastatin

N = 63

Time pre-transition blood test until transition date

Median 99.5 days

Mean 123.3 days

Time transition date until post-transition blood test

Median 180 days

Mean 209 days